Global Venturing Review

The Big Ones Cancer test developer Freenome has closed a $270m series C round that included Novartis and existing backers GV, Kaiser Permanente Ventures and Roche Venture Fund to hike its overall funding to $507m. The capital will be allocated to a clinical study for a blood test Freenome is developing for colorectal cancer screening, … Continue reading "31 August 2020 – Ant Group Files for Dual Listing to Potentially Raise $30bn"